Fibrogen Inc CS (FGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FGEN | AMLX | ELYM | ||
| Company | Fibrogen Inc CS | Amylyx Pharmaceuticals Inc | Eliem Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3000 | 2.03 | 4.50 | ||
| High | 1.3300 | 2.03 | 4.50 | ||
| Low | 1.2400 | 2.03 | 4.50 | ||
| Last | 1.2700 | 2.03 | 4.50 | ||
| Change | -0.0300 | +0.03 | +0.07 | ||
| % Change | -2.31% | +1.50% | +1.58% | ||
| Volume | 1,031,400 | 1,619 | 476 | ||
| 20-Day Average Volume | 1,894,110 | 2,299,746 | 2,103,959 | ||
| Previous Close | 1.3000 | 2.00 | 4.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8840 | 2.51 | 3.27 | ||
| 20-Day Raw Stochastic | 5.55% | 4.76% | 74.16% | ||
| 20-Day Relative Strength | 38.35% | 23.59% | 70.43% | ||
| Weighted Alpha | -79.94 | -68.72 | +14.98 | ||
| Today's Opinion | 8% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 8% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.19% since 04/10/24 | -11.35% since 04/11/24 | -1.75% since 04/11/24 | ||
| Low | 1.2300 on 04/12/24 | 1.98 on 04/16/24 | 4.30 on 04/12/24 | ||
| High | 1.4650 on 04/11/24 | 2.29 on 04/12/24 | 5.19 on 04/15/24 | ||
| 1-Month | |||||
| %Chg | -39.23% since 03/15/24 | -29.02% since 03/18/24 | +60.14% since 03/18/24 | ||
| Low | 1.1801 on 04/03/24 | 1.98 on 04/16/24 | 2.52 on 04/05/24 | ||
| High | 2.8000 on 03/25/24 | 3.03 on 03/21/24 | 5.19 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | +69.33% since 01/17/24 | -86.36% since 01/18/24 | +51.52% since 01/18/24 | ||
| Low | 0.7500 on 01/18/24 | 1.98 on 04/16/24 | 2.52 on 04/05/24 | ||
| High | 2.9300 on 02/12/24 | 19.95 on 02/29/24 | 5.19 on 04/15/24 | ||
| 6-Month | |||||
| %Chg | +94.96% since 10/17/23 | -88.07% since 10/18/23 | +72.41% since 10/18/23 | ||
| Low | 0.3333 on 11/10/23 | 1.98 on 04/16/24 | 2.35 on 12/11/23 | ||
| High | 2.9300 on 02/12/24 | 19.95 on 02/29/24 | 5.19 on 04/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 125,439 | 135,564 | 122,795 | ||
| Shares Outstanding, K | 98,771 | 67,782 | 27,719 | ||
| Annual Sales | 147,750,000 | 380,790,000 | 0 | ||
| Annual Net Income | -284,230,000 | 49,270,000 | -35,120,000 | ||
| Last Quarter Sales | 27,140,000 | 108,450,000 | 0 | ||
| Last Quarter Net Income | -56,230,000 | 4,730,000 | -3,640,000 | ||
| 60-Month Beta | 0.70 | -0.93 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | 0.07 on 02/22/24 | -0.15 on 11/14/23 | ||
| Latest Earnings Date | 05/13/24 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 03/28/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 2.87 | 0.00 | ||